Inventor · disambiguated record
Daniel Ladant
Also filed as: LADANT DANIEL
14 granted patents·11 pending applications·209 citations·filing 1989–2016
92Inventor score
Files withPASTEUR INSTITUT10DADAGLIO GILLES4LECLERC CLAUDE2PREVILLE XAVIER-EDMOND-EDOUARD2CENTRE NAT RECH SCIENT1
Top patents by PatentIndex Score
25 records- 0185US5503829ARecombinant mutants for inducing specific immune responsesPASTEUR INSTITUT·Filed 1994·Granted Apr 2, 1996·58 cites·9 claims
- 0283US8628779B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereofPREVILLE XAVIER-EDMOND-EDOUARD·Filed 2006·Granted Jan 14, 2014·8 cites·43 claims
- 0381US7906123B1Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereofPASTEUR INSTITUT·Filed 2007·Granted Mar 15, 2011·8 cites·17 claims
- 0479US8637039B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereofPREVILLE XAVIER-EDMOND-EDOUARD·Filed 2010·Granted Jan 28, 2014·5 cites·45 claims
- 0575US5679784ARecombinant mutants for inducing specific immune responsesPASTEUR INSTITUT·Filed 1995·Granted Oct 21, 1997·23 cites·10 claims
- 0672US6333154B1Bacterial multi-hybrid system and applications thereofPASTEUR INSTITUT·Filed 1998·Granted Dec 25, 2001·48 cites·21 claims
- 0772US5935580ARecombinant mutants for inducing specific immune responsesPASTEUR INSTITUT·Filed 1995·Granted Aug 10, 1999·33 cites·15 claims
- 0871US9410139B2Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigensDADAGLIO GILLES·Filed 2008·Granted Aug 9, 2016·3 cites·5 claims
- 0969US9370564B2Vectors for molecule delivery to CD11b expressing cellsLECLERC CLAUDE·Filed 2011·Granted Jun 21, 2016·2 cites·22 claims
- 1059US9387243B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereofPASTEUR INSTITUT·Filed 2013·Granted Jul 12, 2016·0 cites·33 claims
- 1154US10004794B2Vectors for molecule delivery to CD11b expressing cellsPASTEUR INSTITUT·Filed 2016·Granted Jun 26, 2018·0 cites·16 claims
- 1251US5183745AAdenyl cyclase derivatives and their biological usesPASTEUR INSTITUT·Filed 1989·Granted Feb 2, 1993·21 cites·18 claims
- 1351US2005238637A1Vectors for molecule delivery to CD11b expressing cellsCENTRE NAT RECH SCIENT·Filed 2005·Application pending·0 cites
- 1450US2005271679A1Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigensDADAGLIO GILLES·Filed 2004·Application pending·0 cites
- 1550US2014227323A1Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigensDADAGLIO GILLES·Filed 2013·Application pending·0 cites
- 1646US2010310594A1Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigensINST PASTEUR A CORP OF FRANCE·Filed 2010·Application pending·0 cites
- 1746US2004001867A1Vectors for molecule delivery to CD11b expressing cellsFiled 2003·Application pending·0 cites
- 1844US2007026022A1Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigensDADAGLIO GILLES·Filed 2006·Application pending·0 cites
- 1944US2006159697A1Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereofLECLERC CLAUDE·Filed 2005·Application pending·0 cites
- 2044US2002045237A1Bacterial two-hybrid system for protein-protein interaction screening, new strains for use therein, and their applicationsFiled 2001·Application pending·0 cites
- 2142US2002106783A1Bacterial multi-hybrid system and applicationsPASTEUR INSTITUT·Filed 2001·Application pending·0 cites
- 2240US2011065782A1Methods of identifying compounds that inhibit the activation of a biomolecule and methods of treatment using the compoundsMALLIAVIN THERESE·Filed 2009·Application pending·0 cites
- 2337US2003175735A1Recombinant adenylcyclase and use thereof for screening molecules with proteolytic activityFiled 2001·Application pending·0 cites
- 2427US10920212B2Monomeric and functional adenylate cyclase CyaA toxinPASTEUR INSTITUT·Filed 2015·Granted Feb 16, 2021·0 cites·16 claims
- 2524US10760072B2In vivo detection of proteins interaction based on adenylate cyclase hybrid systemLADANT DANIEL·Filed 2015·Granted Sep 1, 2020·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Ladant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →